Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis
ACR Board of Directors Tackles Slate of Business at Annual Meeting
Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.
Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis
Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
Beyond such autoimmune diseases as systemic lupus erythematosus and rheumatoid arthritis, rheumatologists should consider hypothyroidism, dietary issues, and grooming habits in patients with hair loss
ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease
Online progam boasts continuing medical education, learning curriculum for healthcare professionals and students, as well as a smartphone app to help patients track their symptoms
Rheumatologists On The Move
Awards, appointments, and announcements in the world of rheumatology
Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
Event Honors Lupus Patients
The Hospital for Special Surgery Division of Rheumatology held an event “Honoring Lupus Heroes” as part of its 150th anniversary celebration. (posted Nov. 26)
ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?
Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
Mark Shlomchik Awarded Inaugural Lupus Insight Prize
The $200,000 grant will allow Pittsburgh researcher to develop new mouse model. (posted July 22, 2013)
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 18
- Next Page »